Medicare Enrolled

Dr. Jason Chu, M.D.

Pulmonary Disease · Fremont, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2557 MOWRY AVE, Fremont, CA 94538
5107933722
In practice since 2006 (19 years)
NPI: 1972521060 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chu

Dr. Jason Chu is a pulmonary disease specialist in Fremont, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chu performed 2,660 Medicare services across 1,633 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chu received a total of $167,445 from 27 pharmaceutical and/or device companies across 621 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in CA $167,445 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,660
Medicare services
Top 14% in CA for pulmonary disease
1,633
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~140 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
701 $78 $242
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
444 $70 $184
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
240 $8 $104
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
203 $104 $308
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
144 $1 $18
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
119 $13 $64
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
115 $104 $263
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
113 $43 $96
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
99 $109 $317
New patient office visit, complex (60-74 min) 85 $194 $497
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
73 $37 $53
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
67 $72 $120
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
60 $136 $457
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
44 $4 $50
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
34 $89 $312
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
29 $157 $384
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
28 $4 $21
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
19 $154 $340
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
15 $282 $459
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
15 $37 $53
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
13 $7 $76
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$167,445
Total received (2018-2024)
Avg $23,921/year across 7 years
Top 3% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
621
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$133,693 (79.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,719 (11.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,033 (8.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,305
2023
$21,685
2022
$41,839
2021
$39,727
2020
$18,673
2019
$17,853
2018
$9,362

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$15,431
Electromed, Inc.
$2,156
Boehringer Ingelheim Pharmaceuticals, Inc.
$284
GlaxoSmithKline, LLC.
$229
Inspire Medical Systems, Inc.
$177
Novartis Pharmaceuticals Corporation
$27
Top 3 companies account for 97.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$48,663
GlaxoSmithKline, LLC.
$44,975
Mallinckrodt Hospital Products Inc.
$25,457
Boehringer Ingelheim Pharmaceuticals, Inc.
$21,589
Electromed, Inc.
$15,181
Genentech USA, Inc.
$9,013
Gilead Sciences, Inc.
$329
Actelion Pharmaceuticals US, Inc.
$327
Teva Pharmaceuticals USA, Inc.
$240
Novartis Pharmaceuticals Corporation
$186
Bayer HealthCare Pharmaceuticals Inc.
$184
Inspire Medical Systems, Inc.
$177
Mallinckrodt LLC
$143
Janssen Pharmaceuticals, Inc
$122
Regeneron Healthcare Solutions, Inc.
$121
Genentech, Inc.
$112
Astellas Pharma US Inc
$95
GENZYME CORPORATION
$92
Relypsa, Inc.
$90
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$81
SANOFI-AVENTIS U.S. LLC
$80
Monaghan Medical Corporation
$58
Insmed, Inc.
$31
Rigel Pharmaceuticals, Inc.
$26
Mallinckrodt Enterprises LLC
$26
Breathe Technologies, Inc.
$25
Mylan Specialty L.P.
$24
Top 3 companies account for 71.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AeroChamber · Arikayce · BOSENTAN TABLETS · BREO · BREZTRI · CINQAIR · CRESEMBA · DISEASE STATE · DUPIXENT · ENTRESTO · Esbriet · FASENRA · INSPIRE · Letairis · Life2000 Ventilation System · LifeVest · NUCALA · OFEV · OPSUMIT · PRALUENT ALIROCUMAB INJECTION · QVAR · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · Tavalisse · UPTRAVI · Veltassa · XARELTO · XOLAIR · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pulmonary disease in CA.

Looking for a pulmonary disease specialist in Fremont?
Compare pulmonary diseases in the Fremont area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
88
Per 100K population
5.3
County median income
$126,240
Nearest hospital
WASHINGTON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chu is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with speaking/promotional industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chu experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Chu performed 701 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chu receive payments from pharmaceutical companies?
Yes. Dr. Chu received a total of $167,445 from 27 companies across 621 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chu's costs compare to other pulmonary diseases in Fremont?
Dr. Chu's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →